Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can better nutrition and cheap worm treatment stop TB?

NCT ID NCT03598842

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at why some people infected with TB bacteria get sick while others don't. Researchers in India studied 120 household contacts of TB patients, comparing those who were malnourished or had parasitic worms. They provided food and deworming medication to see how these factors change the immune system's response to TB. The goal is to find low-cost ways to prevent active TB.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

786 people

The number who actually took part.

Started

Jul 2019

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Household Contacts * Household contact that has been housemate of eligible index case for at least the last month (See index case criteria below). * HIV seronegative * Willing to be tested for pregnancy if married * Age 18-60 years * Willingness by the patient to attend scheduled follow-up visits and undergo study assessments * Able to provide informed consent * Intervention inclusion: On average, one meal consumed at home per day. Exclusion Criteria: Household Contacts * In the team's judgement, individual is not expected to survive for 12 months * HIV infection or not willing to undergo HIV testing (if no documented HIV test) * Pregnant at enrollment * Known diabetes mellitus or evidence of diabetes on hemoglobin A1C (HA1C) * Xpert positive among those able to produce sputum * TB symptoms (night sweats, weight loss, cough) - Only if sputum positive * Any history of TB disease during their lifetime * We will retrospectively exclude household contacts of presumed TB cases whose cultures do not confirm Mtb or who are Xpert negative. * Evidence of kwashiorkor (pitting edema of foot or lower leg) those with BMI \<16 * Abnormal K, Mg, Phos in those with BMI \<16 Inclusion Criteria: Index Case * Sputum Ziehl-Neelsen stain positive for acid-fast bacillus (AFB) ≥1+ * Culture or Xpert positive for Mtb; those who are smear+ but ultimately Xpert or culture negative, will be included until their culture results return at which time they will retrospectively be removed from the study. * No history of TB treatment (i.e., no history of partial or complete treatment for a previous TB episode) * Has at least 1 household contact with whom they have shared a house during the previous one month * Agrees to have household contact notified about study Exclusion Criteria: Index Case * Pregnant at enrollment * No Xpert or culture confirmation and unable to provide sputum sample * No household contacts who share room * Known Multidrug-resistant tuberculosis (MDR-TB) or extensively drug-resistant tuberculosis (XDR-TB) case * BMI \<14 kg/m2 * Abnormal K, Mg, Phos in those with BMI 14 - 16 * Lower extremity edema/kwashiorkor those with BMI 14-16 * Reported neuropathy in lower extremities (may result from thiamine deficiency)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Helminth infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jawaharlal Institute of Postgraduate Medical Education and Research

    Pondicherry, Tamil Nadu, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.